Clinical trial
Phase I Dose-Finding Study of E7070 in Combination With Irinotecan
NCT00060567 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Dose-Finding Study of E7070 in Combination With Irinotecan
- Lead sponsor
- Eisai Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 31, 2003
- Completion date
- March 31, 2013
- Enrollment
- 88 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer